Genomic analysis of tumor cells revealed a slight elevation in the frequency of disease-relevant somatic variations (e.g., in TP53, PTEN, and RB1) and of DNA amplifications/deletions in metastatic tumors, and minimal changes in the mutation pattern, relative to PT (6–10). The gene discussed is TP53; the disease is neoplasm.